KalVista Pharmaceuticals, Inc. (KALV)

NASDAQ: KALV · Real-Time Price · USD

15.51

+0.50 (3.33%)

At close: Feb 11, 2026, 4:00 PM EST

15.60

+0.09 (0.58%)

Pre-market: Feb 12, 2026, 7:29 AM EST

KalVista Pharmaceuticals Employees

KalVista Pharmaceuticals had 270 employees as of April 30, 2025. The number of employees increased by 120 or 80.00% compared to the previous year.

Employees

270

Change (1Y)

120

Growth (1Y)

80.00%

Revenue / Employee

$5,281

Profits / Employee

-$752,211

Market Cap

783.97M

Employees Chart

Date	Employees	Change (1Y)	Growth (1Y)
Apr 30, 2025	270	120	80.00%
Apr 30, 2024	150	32	27.12%
Apr 30, 2023	118	13	12.38%
Apr 30, 2022	105	35	50.00%
Apr 30, 2021	70	14	25.00%
Apr 30, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Apr 30, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Apr 30, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Apr 30, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Jul 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Apr 30, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Company Name	Employees
MiMedx Group	837
Maravai LifeSciences Holdings	550
Omeros	202
Janux Therapeutics	109
Annexon	99
AgomAb Therapeutics NV	58
Arbutus Biopharma	44